Golidocitinib
Golidocitinib (AZD4205) is a selective JAK1 inhibitor, with an IC50 of 73 nM, weakly inhibits JAK2 (IC50>14.7 μM), and shows little inhibition on JAK3 (IC50>30 μM) [1].
Product Specifications
CAS Number
[2091134-68-6]
Product Name Alternative
AZD4205
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/AZD-4205.html
Purity
99.54
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
C[C@@H](N1CCN(C)CC1)C(NC2=C3C(C(C4=NC(NC5=CN(C)N=C5OC)=NC=C4)=CN3)=CC=C2)=O
Molecular Formula
C25H31N9O2
Molecular Weight
489.57
References & Citations
[1]Annika Birgitta Margareta ÅSTRAND, et al. Compounds and methods for inhibiting jak. WO2017050938A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Isoform
JAK1
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6185802 1.0 µg DNA
Ccdc27 sgRNA CRISPR Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details 
GTR15326795 1 Vial
Lentiviral human CDK5RAP1 shRNA (UAS) - Lentiviral human CDK5RAP1 shRNA (UAS, GFP) (25)
Sign In for Pricing
View Details 
